What is it?
Albupax is the first generic version of the international brand – Abraxane of Abraxis BioSciences, USA. Albupax has been indigenously developed by Natco in India and is the first albumin bound Paclitaxel in nanoparticle to be developed in India.
What is it used for?
Albupax, consists of Paclitaxel in an albumin bound nanoparticle form, is used in the treatment of breast cancer.
Albupax replaces the conventional Paclitaxel and has the advantage of having fewer side effects. In the conventional Paclitaxel, the solvent polyethylated castor oil is used, which causes severe side effects such as neutropenia, hyper-sensitivity reactions and neuropathy. Albupax does not contain this solvent, and hence can be given in optimum doses for enhanced efficacy. |
